CONMED Corp Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2011 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
CONMED Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2011 to Q1 2024.
- CONMED Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $1.87M.
- CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2023 was $700K.
- CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$6.04M, a 301% decline from 2021.
- CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2021 was $3.01M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)